DCT

3:19-cv-08233

Valeant Pharma North America LLC v. Mylan Pharma Inc

General
Filed
03/08/19
Cause of ActionInfringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Judge
Period
PO Win Rate
--
70%
Defendant
Party
Attorney